| Business Name: |
Aditi G Gulabani M D |
| Contact Person: |
Aditi G Gulabani |
| Address: |
437 Sword Way, Bolingbrook, Illinois 60440 |
| Phone Number: |
(630) 965-7006 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2011 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
621111 |
| Share This Business: |
|
| Related Businesses: |
Medavaram Meher MD - Bolingbrook, IL 60440
Edward Healthcare Center - Bolingbrook, IL 60440
Malicay Manuel MD - Bolingbrook, IL 60440
Downers Grove Pediatrics Ltd - Bolingbrook, IL 60440
Mohiuddin Ali M MD - Bolingbrook, IL 60440
Rao Jagadish K Padmaja - Bolingbrook, IL 60440
York Ent Surgical Consultants - Bolingbrook, IL 60440
Stephen P Holland - Bolingbrook, IL 60440
Cabana E C MD - Bolingbrook, IL 60440
Pitsilos George MD - Bolingbrook, IL 60440
Gorovits Anatoly MD - Bolingbrook, IL 60440
Sauer Paul MD - Bolingbrook, IL 60440
Holland Steve MD - Bolingbrook, IL 60440
Riginald S Picache Inc - Bolingbrook, IL 60440
Onagan Maria I MD - Bolingbrook, IL 60440
Meyer Karenmarie MD - Bolingbrook, IL 60440
Chittineni Bharati MD - Bolingbrook, IL 60440
Ahmed Irma MD - Bolingbrook, IL 60440
Akl Youssef Emile MD - Bolingbrook, IL 60440
Khan Mohammad M MD - Bolingbrook, IL 60440
|
The company Aditi G Gulabani M D provides B2C services in the form of Doctors from its single location in Illinois.
1 to 4 employees work for Aditi G Gulabani M D, and the business now earns $100.000 to $499.999 per annum.
Aditi G Gulabani M D was launched in 2011 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Aditi G Gulabani M D, please call Aditi G Gulabani with the phone number (630) 965-7006 or visit its single location at 437 Sword Way in Bolingbrook, Illinois 60440.
The location of the single location can also be found using the coordinates 41.712047,-88.04538.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.